These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12463301)

  • 21. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.
    Vancelik S; Beyhun NE; Acemoglu H; Calikoglu O
    BMC Public Health; 2007 Jun; 7():122. PubMed ID: 17592644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closing the sample closet.
    Sanders J
    Fam Pract Manag; 2006; 13(10):16, 21; author reply 21. PubMed ID: 17144005
    [No Abstract]   [Full Text] [Related]  

  • 23. Sources of drug information used by general practitioners.
    Eaton G; Parish P
    J R Coll Gen Pract; 1976; 26 Suppl 1(Suppl 1):58-64. PubMed ID: 1011221
    [No Abstract]   [Full Text] [Related]  

  • 24. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 25. Most drug freebies go to well-off: study. Research suggests race, gender a factor, too, but drug group calls research flawed.
    Rhea S
    Mod Healthc; 2008 Jan; 38(1):12-3. PubMed ID: 18273965
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct-to-consumer advertising--strengthening our health care system.
    Holmer AF
    N Engl J Med; 2002 Feb; 346(7):526-8. PubMed ID: 11844858
    [No Abstract]   [Full Text] [Related]  

  • 27. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 28. The Massachusetts drug formulary.
    N Engl J Med; 1971 Jul; 285(4):232-3. PubMed ID: 5087728
    [No Abstract]   [Full Text] [Related]  

  • 29. Marketplace. Managed care plans try to cope as drug ads spur patient demand.
    Moskowitz DB
    Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing: what's all the fuss?
    Shakib S; George A
    Aust Fam Physician; 2003; 32(1-2):35-8. PubMed ID: 12647657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing with an empty pharmacy: drug shortages update for the clinical nurse specialist.
    O'Malley PA
    Clin Nurse Spec; 2014; 28(5):261-3. PubMed ID: 25111403
    [No Abstract]   [Full Text] [Related]  

  • 33. Perspectives. Drug formularies pose legal threat to providers.
    Moskowitz DB
    Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
    [No Abstract]   [Full Text] [Related]  

  • 34. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of automatic data processing of receipts in the control of prescriptions].
    Modr Z; Stika L
    Zdrav Aktual; 1979; 191():77-87. PubMed ID: 550643
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug makers battle a U.S. plan to curb rewards for doctors.
    Pear R
    N Y Times Web; 2002 Dec; ():A1, A28. PubMed ID: 12561833
    [No Abstract]   [Full Text] [Related]  

  • 38. [Automatic processing of drug traffic and consumption in pharmacies].
    Gradisnik D
    Nar Zdrav; 1976; 32(12):85-7. PubMed ID: 1028925
    [No Abstract]   [Full Text] [Related]  

  • 39. Friction and fact in the marketing of pharmaceuticals and biologics.
    Herrick JB
    J Am Vet Med Assoc; 1992 Aug; 201(4):556-7. PubMed ID: 1517128
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.